• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Future Innovations for HS Diagnosis and Management

Author(s):

Merrick D. Elias, DO, FAAD,Hadar Avihai Lev-Tov, MD

Panelists discuss future innovations in hidradenitis suppurativa (HS) treatment and recommendations for guidelines and support groups.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

      Subscribe Now!
      Related Videos
      4 experts are featured in this series.
      What Lies Ahead for GPP Diagnosis and Management
      4 experts are featured in this series.
      Case 3: High-Risk Patient with GPP Treatment Approach
      2 experts in this video
      Future Directions for IL-17 Inhibitors in Psoriasis and Psoriatic Arthritis Care
      1 expert in this video
      Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?
      1 expert in this video
      Treatment Escalation and De-escalation Strategies in Pediatric AD: Positioning Ruxolitinib Cream in Clinical Decision-Making
      1 expert in this video
      Benefits of Nonsteroidal Topical JAK Inhibitors for Moderate Pediatric Atopic Dermatitis
      1 expert in this video
      Identifying and Addressing Critical Gaps in Pediatric Atopic Dermatitis Treatment with Ruxolitinib Cream
      4 experts are featured in this series.
      Utility of Head-to-Head Studies in Atopic Dermatitis and Future Research Directions
      2 experts in this video
      Utility of Head-to-Head Studies in Psoriasis Management
      1 expert in this video
      Things to Consider With Treatment Sequencing for Pediatric Atopic Dermatitis
      Related Content
      Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care
      April 4th 2025

      Patient Survey Highlights Dissatisfaction and Undertreatment in Hidradenitis Suppurativa Care

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology
      June 25th 2020

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2
      March 21st 2025

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1
      March 18th 2025

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1

      Povorcitinib Demonstrates Promising Phase 3 Results for Hidradenitis Suppurativa Treatment
      March 17th 2025

      Povorcitinib Demonstrates Promising Phase 3 Results for Hidradenitis Suppurativa Treatment

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis
      March 14th 2025

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis

      © 2025 MJH Life Sciences

      All rights reserved.